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New Translocations in Human
Lymphocytes: A Mutagen
Monitoring System
by Frederick Hecht,* Barbara Kaiser McCaw,* David
Peakman,*t and Arthur Robinsont
The human lymphocyte is a premier cell for monitoring chromosome aneuploidy. The lymphocyte is
easily obtained, can be studied before and after culture, and has been extensively investigated.
Assays available for lymphocytes indclude the scoringofchromosome breaks (subjective and laborious),
the analysis ofchromosome abnormalties such as increase or decrease in number (versus normal back-
ground), dicentrics etc., and the micronucleus test (presumable end-state phenomena). We propose the
monitoringofsomaticchromosometranslocations inhumanlymphocytes. Backgrounddataavailable from
North America indicate that the frequency ofde novo chromosome translocations in Halifax, Portland,
Denver,andAtlantaisabout 1.7 x 10-3. Themostcommontranslocation arisinginlymphocytesisbetween
chromosomes 7 and 14 (with a frequency of 4 x 10-4. AU translocations occurring de novo in human
lymphocytes tend to appear balanced with no evidence for loss or gain ofchromosome material.
Cytogenetic laboratories are processing lymphocytes daily. The resultant photographs and karyotypes
areallscorableforde novotranslocations. Suitable dataonexposuretopossible mutagenic agentscould be
collected in advance of these chromosome studies. This would provide a new method for monitoring
chromosome changes in the population.
, The cost of monitoring lymphocyte chromosomes for somatic translocations would be small, since
numerous laboratories study lymphocytes routinely for clinical diagnostic purposes.
There may be merit in availing ourselves ofeasily available data from a very available species: man.
A major concern ofhuman genetics is to establish
andthenmonitormutation rates. There are anumber
ofways the establishment and monitoring ofhuman
mutation rates can be approached.
We will illustrate two general models first in rela-
tion to meiotic chromosome mutations. Let us take,
for example, Down's syndrome, the commonest
autosomal chromosome abnormality in newborn
babies. (incidence at birth -650).
Types of Studies
Prospective Model
We plan togatherdata on the incidence ofDown's
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syndrome atbirth. We may select apopulation sam-
ple and then gather prospective data pertaining to
parental age, x-ray exposure, drug and chemical ex-
perience in that population (before or during preg-
nancy). Nextwe screen all babies born to this popu-
lation for Down's syndrome. Then we calculate the
incidence to see if it is in the expected range.
Retrospective Model
We take advantage of data accumulating in
cytogenetic laboratories. We will probably not have
complete samplingofthe populationatrisk. We will,
however, have datafrom alreadyfinished diagnostic
cytogenetic studies. Further we will have several
different categories ofDown's babies: A = number
oftrisomy 21 babies; B = number ofbabies with de
novo translocations; C = number ofbabies with in-
herited translocations; D = number of babies with
trisomy21/normal mosaicism. Frompastexperience
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(trisomy 21), 0.02 of the total will be B (de novo
translocations), 0.02 ofthe total will be C (inherited
translocations), and 0.01 of the total will be D
(mosaics).
We look at the real numbers in thefourcategories.
We set up various ratios such as B/(A + B). The
expected ratio ofBI(A + B) would be 0.02. If the
observed ratio during a period of time rose to 0.03,
we would suspect an increase in de novo chromo-
some translocations. Since the altered ratio might
equally well reflect a relative decrease in trisomy 21
(nondisjunction), we might then examine the ratio
BIC, which would be expected a priori to be 1.0. If
B/C were observed to be 1.5, this would confirm an
increase in de novo translocations.
Prospective Versus Retrospective Models
The prospective model is todesign research, carry
itoutandanalyzetheresults. Itis neatandclean. Itis
also time consuming and expensive.
The retrospective model is to take what data are
available and look at them. This is less tidy and less
elegant, but it is quick and costs little.
Somatic Translocations in
Lymphocytes
We here propose the use of retrospective data
from diagnostic cytogenetic studies oflymphocytes
toestablish and monitor the rate ofsomatic chromo-
some translocations.
Pilot Study in Denver
We studied lymphocytes cultured in 1974-75 from
300consecutive individuals (1). Twenty metaphases
from each individual were studied foratotal of6,000
metaphases.
The individuals were patients and their relatives
seen for genetic counseling in Denver. The diseases
for which they sought counseling spanned much of
the range of clinical genetics. No individual was
known to have had unusual x-irradiation orchemical
exposure.
The lymphocytes were cultured with phyto-
hemagglutinin for 72 hr and harvested with col-
chicine. Cells were fixed routinely onto slides. The
slides were Giemsa-banded, scanned under low
power microscopy for intact, well-spread meta-
phases, which were then photographed under higher
power. Two ormore karyotypes were prepared from
each individual.
Four of the 6000 metaphases we studied had a
chromosome rearrangement. Each of the four
translocations was found in a solitary cell from a
different unrelated individual. All four of the re-
arrangements involved the same two chromosomes:
7and 14. Thebreakpoints in 14were inbandq12 inall
4cells. The breakpoints in 7 were in bandq13 (1 cell)
orq33-35 (3 cells). All four translocations appeared
"balanced" with no evidence for loss or gain of
chromosome material.
Pilot Studies in Halifax and Atlanta
Studies similar to ours were carried out concur-
rently in Halifax (2) and Atlanta (3). The results
are presented, together with those from Denver, in
Table 1.
Somatic Translocation Rates in Pooled
3-Center Sample
Rates of occurrence of somatic translocations in
the three pilot studies can be calculated. The rates
may be ofvalue, since all datafrom the three centers
were obtained in 1974-75 employing similar pro-
tocols.
The frequency of7/14 translocations in the three-
center sample was 12/1402 = 1 per 117 individuals.
The frequency of other (non-7/14) translocations
in the three-center sample was 43/1,402 = 1 per 33
individuals.
The frequency of all de novo translocations can
also be calculated from Table 1. Per person, there
were 55 in 1402 or 1 in 25 to 1 in 26 individuals.
Somatic Translocation Rates in Halifax and
Atlanta
As will be discussed below, Denver's cumulative
experience with somatic translocations in cultured
lymphocytes is now available. Excluding Denver,
there were eight translocations involving chromo-
somes 7 and 14 in 1102 persons or 1 per 138 indi-
viduals.
Denver Cumulative Experience
Since chromosome banding was instituted in the
Clinical Cytogenetics Laboratory at University of
Colorado Medical Center and National Jewish Hos-
pital, approximately 40,000 cells from 2500 persons
have been studied and 17 cells with a7/14 transloca-
tion, each from a different person, have been ob-
served.
The rate ofoccurrence therefore was 17/2500 = 1
per 147 persons. Cumulative data are not yet avail-
ablefrom Denveron othertranslocations (otherthan
those of the 7/14 type).
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Lymphocytes Translocations
No. of
Center individuals Per individual Total 7/14 Other All
Denver 300 20 6,000 4 0 4
Halifax 250 20 5,000 3 6 9
Atlanta 852 25 21,300 5 37 42
Totals 1,402 20-25 32,300 12 43 55
Table 2. Rates of occurrence of 7/14 translocations
in cultured lymphocytes.
7/14 No. of Translocations
Translocations individuals per person
Halifax and Atlanta 8 1,102 1/138
Denver 17 2,500 1/147
All centers 25 3,602 1/144
Discussion
The human lymphocyte is a suitable cell for
monitoring mutagenesis. Several features make the
lymphocyte favorable: the lymphocyte is easily ob-
tained; the lymphocyte is in suspension as a single
cell; the lymphocyte can be studied at various
times-immediately after being obtained, after
short-term culture, orafterlonger periods in culture;
Chromosomes in lymphocytes can be conveniently
studied; the human lymphocyte is a human cell, so
extrapolation from another species to Man is not
needed.
In view ofthese and other favorable features, we
have proposed the monitoring of somatic transloca-
tions in cultured human lymphocytes as a way of
detecting environmental mutagenesis.
The 7/14 translocations, which predominate in
lymphocytes (1-2), warrant comment. We have ob-
served clones oflymphocytes with translocations in
patients with ataxia-telangiectasia (3), an autosomal
recessive disorder predisposing to lymphoreticular
malignancy. The clones in ataxia-telangiectasia
often are marked by 7/14 translocations indistin-
guishable from those reported here in isolated cells
from individuals who do not have A-T. Possible ex-
planations for this include (a) coincidence, (b) non-
random production of or selection for 7/14 translo-
cations (1-3), and (c) expression of heterozygosity
for ataxia-telangiectasia. We have speculated also
about the possible malignant potential of7/14 trans-
location lymphocytes (4).
Since the rates of7/14 translocations in the studies
reported here were relatively constant, any increase
in rate would suggest increased exposure to muta-
gens (or carcinogens).
Other cytogenic assays are, of course, available
and may also be ofvalue with lymphocytes, includ-
ing: scoring of chromosome breaks (subjective and
laborious), scoring deviations in chromosome num-
ber (large numbers of cells needed), and the mi-
cronucleus assay (the micronucleus presumably be-
tokens an end-stage cell with a fatal chromosome
aberration).
Proposal
Cytogenetic laboratories are processing lympho-
cytes daily. The resultant photographs and karyo-
types are scored for de novo translocations. A
translocation in a lymphocyte can be detected soon
afterits occurrence. The cost ofmonitoring lympho-
cyte chromosomes for translocations is small.
Numerous laboratories study lymphocytes routinely
for clinical diagnostic purposes. (The average labo-
ratory studies 400-600 individuals per year).
The collection ofdatafrom 100 laboratories would
thus yield dataon about 50,000 individuals per year.
One would expect in the neighborhood ofabout 347
persons in 50,000(1 per 144) to have acell with a7/14
translocation. If, for example, 387 persons were
noted to have a 7/14 translocation cell, this would be
a statistically significant increase (p < 0.05) in the
rate ofoccurrence and should lead to concern about
mutagen exposure.
Summary
We propose that human lymphocytes be moni-
tored for de novo translocations, especially of the
7/14 type, to help detect environmental mutagens.
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